Alkermes’ Pops Lays Out Novel Drug Vision For Year Ahead

 
• By Mandy Jackson
  
Richard Pops, CEO of Alkermes
Alkermes CEO Richard Pops is focused on novel drugs going forward • Source: Alkermes PLC
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business